ADCT

Adc Therapeutics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Adc Therapeutics sales and earnings growth
ADCT Growth
Good
  • Revenue Y/Y↓ -18.55%
  • EPS Y/Y↑ 30.77%
  • FCF Y/Y↑ 16.65%
Adc Therapeutics gross and profit margin trends
ADCT Profitability
Low
  • Gross margin ↑ 90.70%
  • EPS margin↓ -173.00%
  • ROIC 5Y↓ -83.97%
Adc Therapeutics net debt vs free cash flow
ADCT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1.6

Adc Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks